Jobs at Computer & Info. Sciences at the Univ. of Delaware (Now Hiring) — 65 open — Page 4

 

Under general direction of the Laboratory Operations Manager the Laboratory Equipment Manager is responsible for ensuring the capital assets and equipment needed for the technical operations at the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) are in good working order. The work will involve a wide range of equipment including prototype and commercially available instrumentation. This individual will ensure the safe, organized, and efficient operation of these assets to ensure alignment with the needs of the laboratory staff.

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is dedicated to supporting the manufacturing of biopharmaceuticals. NIIMBL is established by a cooperative agreement with the National Institute of Standards and Technology (NIST) as a public/private consortium of member organizations, including industry, academia, non-profit organizations, state governments, and federal agencies, and is a member of the Manufacturing USA network of institutes funded by the federal government to advance United States competitiveness in advanced manufacturing innovation. Institutionally at the University of Delaware, NIIMBL reports to the Vice President for Research, Scholarship & Innovation.

The most high-profile activities that NIIMBL does are the execution of technical projects to advance the readiness levels of relevant technologies, assays, and methods. These projects include scopes of scientific work that generally include many organizations as partners and collaborators. For example, a project may involve experimental studies, at a level consistent with best practices found in the biopharmaceutical industry, and include scientists from several large and small companies, a scientist from a federal agency, and a scientist from a University. Many of these projects will be hosted at the University of Delaware in a state-of-the-art laboratory facility purpose-built for such studies. These projects will involve a diverse set of technologies and approaches and address drug substance, drug product, and analytical needs by the industry appropriate to several types of biopharmaceuticals: vaccines, therapeutic proteins and antibodies, antibody-drug conjugates, bispecific antibodies, gene therapy vectors, and cell therapies, among others.